{"comparisonGroups":["Control","Myocardial-intrinsic defects"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs myocardial intrinsic defects","group_a_title":"Control group with no myocardial defects. Provides a reference point for comparison with the myocardial-intrinsic defects group.","group_b_title":"Group with myocardial-intrinsic defects. Represents the experimental group with induced myocardial defects for comparison against the control group.","id":"MTBLS4176_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS4176","studyUrl":"http://integmet.org/study/MTBLS4176","title":"Control_vs_Myocardial_intrinsic_defects","topHits":[{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0382097857614167,"ratio":0.0006962573395319,"synonym_name":"GMP"},{"chebi_id":"456215","direction":"down","inn_name":"","iupac_name":"5'-<em>O</em>-phosphonatoadenosine","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-L","pvalue":1.36813886753243e-05,"ratio":0.342615069942859,"synonym_name":"AMP dianion"},{"chebi_id":"46398","direction":"up","inn_name":"","iupac_name":"uridine 5'-triphosphate(4\u2212)","metabolite_id":"PGAVKCOVUIYSFO-XVFCMESISA-J","pvalue":0.0031057016256652,"ratio":7.232553147692429,"synonym_name":"URIDINE 5'-TRIPHOSPHATE"},{"chebi_id":"57600","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]guanosine","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-K","pvalue":0.0054435892167359,"ratio":5.8114033322939544,"synonym_name":"GTP trianion"},{"chebi_id":"57299","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-K","pvalue":0.0243410870455475,"ratio":2.1525077658869973,"synonym_name":""}],"totalFeatures":11}
